Paul Trippier

Find an error

Name:
Organization: Texas Tech University Health Sciences Center
Department: Department of Pharmaceutical Sciences, School of Pharmacy
Title:
Co-reporter:Nihar Kinarivala, Kaushik Shah, Thomas J. Abbruscato, and Paul C. Trippier
ACS Chemical Neuroscience 2017 Volume 8(Issue 1) pp:
Publication Date(Web):October 10, 2016
DOI:10.1021/acschemneuro.6b00208
The PC12 cell line is a widely used in vitro model for screening the neuroprotective activity of small molecule libraries. External insult due to serum deprivation or addition of etoposide induces cell death by apoptosis. While this screening method is commonly used in early stage drug discovery no protocol accounting for cell passage number effect on neuroprotective activity has been disclosed. We herein report that passage variation results in false-positive/false-negative identification of neuroprotective compounds; undifferentiated PC12 cells with high passage number are less sensitive to injury induced by serum-deprivation or etoposide treatment. In contrast, NGF differentiated PC12 cells of later passage number are more sensitive to injury induced by etoposide than lower passage number but only after 72 h. Passage number also affects the adherence phenotype of the PC12 cells, complicating screening assays. We report an optimized protocol for screening the neuroprotective activity of small molecules in PC12 cells, which accounts for passage number variations.Keywords: apoptosis; cell viability; neuroprotection assay; PC12 cells; protocol; screening;
Co-reporter:Nihar Kinarivala;Paul C. Trippier
Journal of Medicinal Chemistry 2016 Volume 59(Issue 10) pp:4415-4427
Publication Date(Web):November 13, 2015
DOI:10.1021/acs.jmedchem.5b01020
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited and incurable neurodegenerative disorders primarily afflicting the pediatric population. Current treatment regimens offer only symptomatic relief and do not target the underlying cause of the disease. Although the underlying pathophysiology that drives disease progression is unknown, several small molecules have been identified with diverse mechanisms of action that provide promise for the treatment of this devastating disease. This review aims to summarize the current cellular and animal models available for the identification of potential therapeutics and presents the current state of knowledge on small molecule compounds that demonstrate in vitro and/or in vivo efficacy across the NCLs with an emphasis on targets of action.
Co-reporter:Kshitij Verma, Tianzhu Zang, Nehal Gupta, Trevor M. Penning, and Paul C. Trippier
ACS Medicinal Chemistry Letters 2016 Volume 7(Issue 8) pp:774
Publication Date(Web):June 22, 2016
DOI:10.1021/acsmedchemlett.6b00163
We report the design, synthesis, and evaluation of potent and selective inhibitors of aldo-keto reductase 1C3 (AKR1C3), an important enzyme in the regulatory pathway controlling proliferation, differentiation, and apoptosis in myeloid cells. Combination treatment with the nontoxic AKR1C3 inhibitors and etoposide or daunorubicin in acute myeloid leukemia cell lines, elicits a potent adjuvant effect, potentiating the cytotoxicity of etoposide by up to 6.25-fold and the cytotoxicity of daunorubicin by >10-fold. The results validate AKR1C3 inhibition as a common adjuvant target across multiple AML subtypes. These compounds in coadministration with chemotherapeutics in clinical use enhance therapeutic index and may avail chemotherapy as a treatment option to the pediatric and geriatric population currently unable to tolerate the side effects of cancer drug regimens.Keywords: acute myeloid leukemia; adjuvant; AKR1C3 Inhibitor; daunorubicin; etoposide; synergism;
Co-reporter:Nihar Kinarivala, Ji Ho Suh, Mina Botros, Paul Webb, Paul C. Trippier
Bioorganic & Medicinal Chemistry Letters 2016 Volume 26(Issue 8) pp:1889-1893
Publication Date(Web):15 April 2016
DOI:10.1016/j.bmcl.2016.03.028
We report the pharmacophore of the peroxisome proliferator-activated receptor δ (PPARδ) agonist natural product phosphoiodyn A is the phosphonate core. Synthesis of simplified phosphonate esters 13 and 15 provide structurally novel, highly selective and potent PPARδ agonists (EC50 = 78 and 112 nM, respectively). Further, both compounds demonstrate significant neuroprotective activity in an in vitro cellular model indicating that phosphonates may be an effective novel scaffold for the design of therapeutics for the treatment of neurodegenerative disorders.
Co-reporter:Nihar Kinarivala, Paul C. Trippier
Tetrahedron Letters 2014 Volume 55(Issue 39) pp:5386-5389
Publication Date(Web):24 September 2014
DOI:10.1016/j.tetlet.2014.08.008
The chemoselectivity of hydrodechlorination in 2-chloropyridine derivatives possessing reduction-sensitive functionalities is examined. The reaction conditions employed tolerate a variety of functionalities illustrating highly chemoselective hydrodechlorination in the presence of nitrile, allyl, terminal olefin, and nitroamine functionalities in excellent yield. Chemoselective deprotection of carboxybenzyl ethers is illustrated in moderate yield.
Co-reporter:Dr. Paul C. Trippier
ChemMedChem 2013 Volume 8( Issue 2) pp:190-203
Publication Date(Web):
DOI:10.1002/cmdc.201200498

Abstract

Biotinylation, the functional appendage of a biotin moiety to a bioactive compound (including small molecules and biological macromolecules), represents a common technique for identification of the intracellular binding partners that underlie the foundation of observed biological activity. Introduction of an attachment tether to the framework of a compound of interest must be planned at an early stage of development, and many considerations apply: 1) region of attachment, so as not to impede the pharmacophore; 2) stability of the parent molecular architecture to biotinylation conditions; 3) regioselectivity for the chosen tethering location over other reactive functionalities; 4) toxicity of reagents if biotinylation is to be performed in vitro; and 5) overall ease of synthesis. This review is intended to serve as a guide for the selection of appropriate tethering modalities. Examples of the common techniques used to affix biotin, including amide bond formation, [3+2] cycloadditions through “click” chemistry, Staudinger ligation, and thioether formation will be discussed, along with analysis of the wider applications of synthetic methodology that have been applied toward the biotinylation of small molecules.

1H-Imidazol-2-amine,4,5-dihydro-N-nitro-1-(3-pyridinylmethyl)-
2-chloro-3-(2-propen-1-yloxy)-Pyridine
Methyl trans-3-Hydroxycinnamate
VERRUCARIN A, 7'-DEOXO-2'-DEOXY-2',3'_9,10-DIEPOXY-9,10-DIHYDRO-4'-HYDROXY-7'-(1-HYDROXYETHYL)-
Carbamic acid, N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-, ethyl ester
(2E)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
Phosphonic acid,P-(2-hydroxyethyl)-
Daunomycin
3-(2-propen-1-yloxy)-Pyridine